HLA

Scope & Guideline

Connecting Researchers: Your Gateway to Open Access Discoveries

Introduction

Welcome to your portal for understanding HLA, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2059-2302
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Converge2011, from 2016 to 2024
AbbreviationHLA / HLA
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'HLA' focuses on the study of human leukocyte antigens (HLA) and their implications for immunology, transplantation, and disease associations. It serves as a platform for disseminating research that advances the understanding of HLA genetics, molecular biology, and clinical applications.
  1. Characterization of Novel HLA Alleles:
    The journal emphasizes the identification and characterization of new HLA alleles through advanced sequencing techniques, which are crucial for understanding genetic diversity and its implications in transplantation and disease susceptibility.
  2. HLA and Disease Associations:
    Research on the association between specific HLA alleles and various diseases, including autoimmune disorders, infectious diseases, and cancers, is a core focus. This includes studies linking HLA polymorphisms to clinical outcomes and disease severity.
  3. Transplantation Immunology:
    The journal covers topics related to HLA's role in transplantation, particularly in understanding donor-recipient compatibility, the development of donor-specific antibodies, and strategies for improving transplant outcomes.
  4. Molecular and Genetic Techniques:
    A significant portion of the research employs next-generation sequencing and other molecular techniques to explore HLA genetics, focusing on high-resolution typing and the implications of genetic variations.
  5. Immunogenetics and Personalized Medicine:
    The integration of immunogenetics into personalized medicine approaches, particularly in transplantation and autoimmune diseases, is a growing area of interest, reflecting the journal's commitment to translational research.
The journal is experiencing a dynamic evolution in its focus areas, with several emerging themes gaining prominence. These trends reflect advancements in technology and shifts in clinical practice.
  1. Next-Generation Sequencing Applications:
    The use of next-generation sequencing for HLA typing and allele discovery is increasingly prominent, enabling more efficient and accurate identification of alleles and enhancing understanding of genetic diversity.
  2. HLA in COVID-19 Research:
    Research linking HLA alleles to COVID-19 susceptibility and outcomes is rapidly emerging, reflecting the pandemic's impact on immunogenetics and highlighting the relevance of HLA in infectious disease response.
  3. Immunogenetic Factors in Transplant Outcomes:
    There is a growing trend towards researching the impact of specific HLA alleles and haplotypes on transplant outcomes, particularly in relation to donor-specific antibodies and graft-versus-host disease.
  4. Integration of Machine Learning in HLA Studies:
    The application of machine learning techniques in analyzing HLA data for predicting transplant outcomes and understanding immunological responses is emerging as a significant trend, indicating a shift towards data-driven approaches.
  5. Personalized Medicine in Transplantation:
    Increasingly, studies are focusing on personalized medicine approaches in transplantation, including the customization of immunosuppressive therapies based on HLA profiles and patient-specific factors.

Declining or Waning

While the journal has seen significant growth in certain areas, there are themes that appear to be declining in prominence. These waning scopes indicate shifts in research focus or decreased publication activity.
  1. HLA Typing Methodologies:
    Research specifically centered on traditional HLA typing methodologies seems to be declining, as there is a noticeable shift towards next-generation sequencing and more advanced molecular techniques.
  2. HLA Antibody Detection Techniques:
    The exploration of older methodologies for HLA antibody detection, such as complement-dependent cytotoxicity assays, has seen reduced publication frequency as newer, more sensitive techniques gain traction.
  3. General HLA Research without Specific Clinical Application:
    There appears to be a waning interest in purely academic studies of HLA without direct clinical implications, as the focus shifts towards translational research that can impact patient care and treatment outcomes.

Similar Journals

Gene Reports

Transforming Genetic Discoveries into Practical Solutions
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Gene Reports is a prominent academic journal published by Elsevier that focuses on the rapidly evolving field of genetics. Launched in 2015, this journal serves as a pivotal platform for the dissemination of cutting-edge research, bridging the gap between basic and applied genetics studies. Although it currently holds a Q4 ranking in the Genetics category and stands at the 248th position out of 347 in Scopus rankings, its potential for growth is significant given the increasing interest in genetic research across various disciplines. With an E-ISSN of 2452-0144, Gene Reports aims to provide open access to original research articles, reviews, and short communications that advance the collective understanding of genetic mechanisms and their applications. As a publication that continues to shape the future of genetics, it is an essential resource for researchers, professionals, and students seeking to stay informed about the latest developments in this crucial field.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Elevating Insights in Genetics and Molecular Medicine
Publisher: TAYLOR & FRANCIS ASISSN: 1473-7159Frequency: 12 issues/year

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, published by Taylor & Francis AS, serves as a pivotal platform for facilitating advanced research and discourse in the fields of Genetics, Molecular Biology, Molecular Medicine, and Pathology. With an impressive Impact Factor and a distinguished status as Q2 in multiple categories, along with a prestigious Q1 ranking in Pathology and Forensic Medicine (2023), this journal continues to attract contributions from leading experts and budding researchers alike. The journal aims to address critical developments in molecular diagnostics, providing insightful reviews that propel the understanding and application of diagnostic techniques in various medical contexts. Accessible to a diverse audience in the academic community, the journal emphasizes the importance of molecular diagnostics in both clinical and laboratory settings, promoting innovative methodologies and comprehensive evaluations of emerging technologies. With ongoing convergence of scientific discovery advancing rapidly from 2001 through 2024, EXPERT REVIEW OF MOLECULAR DIAGNOSTICS remains essential for those committed to furthering the fields of molecular diagnostics and healthcare advancements globally.

Molecular Genetics & Genomic Medicine

Advancing the frontiers of genomic medicine.
Publisher: WILEYISSN: 2324-9269Frequency: 12 issues/year

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

Human Genetics and Genomics Advances

Illuminating the Path of Human Genetics
Publisher: ELSEVIERISSN: 2666-2477Frequency:

Human Genetics and Genomics Advances is a premier academic journal published by Elsevier, dedicated to the field of human genetics and genomic medicine. With an ISSN of 2666-2477, this journal has quickly established itself as a leading platform for disseminating cutting-edge research from its inception in 2020. Featured prominently in Q1 categories for both Clinical Genetics and Molecular Medicine as of 2023, it ranks favorably among its peers, reflected in its Scopus rankings. The journal not only offers valuable insights into the latest advancements and applications in genetics but also facilitates open dialogue among researchers, clinicians, and students. As an open access publication, it ensures that groundbreaking findings in genetics are readily accessible to a global audience, promoting knowledge sharing and collaboration. Human Genetics and Genomics Advances continues to be instrumental in moving the field forward, providing a vital resource for those at the forefront of genetic and genomic research.

Genes and Nutrition

Connecting Genetic Factors to Nutritional Outcomes
Publisher: BMCISSN: 1555-8932Frequency: 1 issue/year

Genes and Nutrition is a prominent open access journal published by BMC in the United Kingdom, dedicated to advancing knowledge at the intersection of nutrition, genetics, and human health. With the aim of making cutting-edge research available to a global audience, the journal has been a vital platform for sharing discoveries since its inception in 2007, and it continues to thrive with a convergence period extending to 2024. Recognized for its high-quality contributions, Genes and Nutrition is rated in the Q2 category within both Endocrinology, Diabetes, and Metabolism and Genetics as of 2023, reflecting its esteemed position in these fields (Scopus Ranks leaderboard places it at #72/244 and #109/347, respectively). This journal is an invaluable resource for researchers, professionals, and students alike, fostering collaboration and innovation in the understanding of how genetic factors influence nutrition and health outcomes. Accessible to all since 2016, it encourages dialogue and discovery, positioning itself as a leader in genetic and nutritional science.

HUMAN GENETICS

Connecting laboratory discoveries with clinical applications.
Publisher: SPRINGERISSN: 0340-6717Frequency: 12 issues/year

HUMAN GENETICS, published by SPRINGER, stands as a cornerstone journal in the field of genetics, offering a wealth of research insights since its inception in 1964. Hailing from Germany, this esteemed journal boasts an impressive Q1 ranking in both Genetics and Clinical Genetics, marking it among the top quartile of journals in these categories for 2023. With a notable Scopus rank of #7 in Clinical Genetics and a percentile ranking of 93, HUMAN GENETICS attracts significant attention from researchers and professionals dedicated to advancing our understanding of genetic influences on human health and disease. Although it does not currently offer Open Access options, the journal provides a critical platform for scholarly communication, aimed at disseminating groundbreaking findings in genetics and biotechnology. As the field evolves, HUMAN GENETICS continues to play an instrumental role in bridging the gap between laboratory research and clinical application, making it an essential resource for students and seasoned researchers alike.

npj Genomic Medicine

Empowering Global Collaboration in Genomics
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Genomic Medicine is a leading open-access journal published by NATURE PORTFOLIO, specializing in the rapidly evolving areas of genomic medicine, including genetics, molecular biology, and clinical applications. Launched in 2016, the journal has quickly established itself within the academic community, boasting a prestigious Q1 ranking in multiple categories, including Genetics and Molecular Biology, with remarkable positions in both Scopus ranks and percentiles. With an emphasis on innovative genomic research that bridges the gap between laboratory findings and clinical implementation, npj Genomic Medicine aims to provide a platform for researchers, professionals, and students to share significant advancements and insights. Being an open-access journal enhances accessibility to cutting-edge research, ensuring that vital discoveries in genomics can benefit a global audience and facilitate interdisciplinary collaboration. The journal continues to contribute to the forefront of genomic research, impacting both academic scholarship and practical healthcare solutions.

Global Medical Genetics

Bridging the Gap Between Genetics and Clinical Practice
Publisher: GEORG THIEME VERLAG KGISSN: 2699-9404Frequency: 4 issues/year

Global Medical Genetics is a premier open-access journal dedicated to advancing the field of medical genetics. Published by GEORG THIEME VERLAG KG, this journal has been providing a dynamic platform for disseminating cutting-edge research and clinical findings since its inception in 2020. With the ISSN 2699-9404, it serves as an essential resource for researchers, healthcare professionals, and students who seek to explore the complex interplay between genetics and medicine. The journal aims to foster collaboration and innovation in the genetics community, addressing a diverse range of topics from genetic disorders to the application of genomics in personalized medicine. By providing open access to its content, Global Medical Genetics enhances knowledge sharing and accelerates advancements in healthcare, making it a vital asset for anyone invested in the future of genetics.

JOURNAL OF MEDICAL GENETICS

Transforming Genetic Discoveries into Clinical Applications.
Publisher: BMJ PUBLISHING GROUPISSN: 0022-2593Frequency: 12 issues/year

JOURNAL OF MEDICAL GENETICS, published by the BMJ PUBLISHING GROUP, stands as a premier platform in the field of genetics, focusing on both fundamental genetic research and its clinical applications. With a distinctive legacy dating back to 1965 and a significant role in advancing the understanding of genetic disorders, this journal has established itself in the top tiers with a commendable Q1 category ranking in both Genetics and Clinical Genetics as of 2023. The journal's impact is underscored by its Scopus rankings, placing it among the leading journals in the fields of medicine and genetics. Researchers and practitioners are drawn to its rigorous peer-review process and its commitment to disseminating high-quality research findings, critical reviews, and innovative clinical practices. While it is not an open-access journal, the insights provided are invaluable for anyone looking to deepen their knowledge or contribute to the burgeoning field of medical genetics.

Human Genomics

Unlocking the Secrets of Human Genetics
Publisher: BMCISSN: 1473-9542Frequency: 1 issue/year

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.